Date:3/26/2009

uarter of 2007. The fourth quarter operating loss reflects a $19.1 million non-cash goodwill impairment charge within one of the Company's specialty packaging businesses driven by the anticipation of a significant reduction in future revenue from a customer that had historically comprised a material portion of the reporting unit's annual revenues. Adjusted for this goodwill impairment charge, unfavorable foreign currency translation of $1.3 million, restructuring activity of $1.5 million, and a related curtailment gain of $3.7 million, operating income for the fourth quarter of 2008 was $5.8 million. This represents a decline of approximately 34% compared to operating income of $8.8 million for the fourth quarter of 2007, also adjusted for restructuring activity of $2.8 million, a $3.1 million write-off of third party due diligence and legal costs related to a potential acquisition that was not consummated, and an unusual insurance gain of $2.0 million. The fourth quarter's decline in earnings was driven by a reduction in sales volumes, offset in part by cost savings from the Company's various productivity and cost reduction programs as well as favorable impact from the Company' third quarter selling price increases.

Operating income for the full year of 2008 was $13.3 million, compared to 2007 operating income of $46.0 million. For the full year, 2008 operating income, adjusted for the aforementioned fourth quarter goodwill impairment charge of $19.1 million, favorable foreign currency translation of $2.0 million, restructuring activity of $9.3 million, and a related curtailment gain of $3.7 million, was $36.0 million. This represents a decline of approximately 27% compared to 2007 operating income of $49.2 million, also adjusted for restructuring activity of $2.9 million, a $3.1 million write-off of third party due diligence and legal costs related to a potential acquisition that was not consummated, and an unusual insurance gain of $2.8 millio
'/>"/>

SOURCE Pregis Corporation Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Related medicine news :

1. Pregis Announces Investor Conference Call to Review Fourth Quarter and Full Year 2008 Financial Results
2. Pregis Announces Third Quarter 2008 Financial Results
3. Pregis Announces Investor Conference Call to Review 2008 Third Quarter Financial Results
4. Pregis Announces Second Quarter 2008 Financial Results
5. Pregis Announces First Quarter 2008 Financial Results
6. Pregis Announces Fouth Quarter and Full Year 2007 Financial Results
7. Pregis Announces Investor Conference Call to Review 2007 Fourth Quarter and Full Year Financial Results
8. Pregis Corporation Appoints New President of Protective Packaging North America
9. Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financial Results
10. Sagent Pharmaceuticals Announces U.S. FDA Approval of Azithromycin for Injection
11. Mylan Announces Intention to Purchase Remaining Interest in Matrix Laboratories and Delist Matrix from Indian Stock Exchanges